These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. TP53 mutation and microsatellite instability status for the prediction of survival in adjuvant-treated colon cancer patients. Watanabe T; Kanazawa T; Kazama Y; Tanaka J; Tanaka T; Ishihara S; Nagawa H J Clin Oncol; 2005 Dec; 23(35):9031-2; author reply 9032-3. PubMed ID: 16339756 [No Abstract] [Full Text] [Related]
6. Microsatellite instability as a molecular marker for very good survival in colorectal cancer patients receiving adjuvant chemotherapy. Elsaleh H; Shannon B; Iacopetta B Gastroenterology; 2001 Apr; 120(5):1309-10. PubMed ID: 11288748 [No Abstract] [Full Text] [Related]
7. [Colon cancer: what is new in 2004?]. André T; Louvet C; de Gramont A Bull Cancer; 2004 Jan; 91(1):75-80. PubMed ID: 14975808 [TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemotherapy in colorectal cancer patients with microsatellite instability. Watanabe T; Kanazawa T; Kazama Y; Tanaka J; Tanaka T; Ishihara S; Nagawa H; Benatti P; Ponz de Leon M; Gafá R; Lanza G; Barana D; Oliani C Clin Cancer Res; 2006 Jun; 12(12):3866-7; author reply 3867. PubMed ID: 16778117 [No Abstract] [Full Text] [Related]
9. Biologic behavior of microsatellite-unstable colorectal cancer and treatment with 5-fluorouracil. Niv Y Isr Med Assoc J; 2005 Aug; 7(8):520-4. PubMed ID: 16106779 [TBL] [Abstract][Full Text] [Related]
10. Association between recurrence of sporadic colorectal cancer, high level of microsatellite instability, and loss of heterozygosity at chromosome 18q. Sarli L; Bottarelli L; Bader G; Iusco D; Pizzi S; Costi R; D'Adda T; Bertolani M; Roncoroni L; Bordi C Dis Colon Rectum; 2004 Sep; 47(9):1467-82. PubMed ID: 15486743 [TBL] [Abstract][Full Text] [Related]
11. A prospective analysis of microsatellite instability as a molecular marker in colorectal cancer. Chang EY; Dorsey PB; Johnson N; Lee R; Walts D; Johnson W; Anadiotis G; Kiser K; Frankhouse J Am J Surg; 2006 May; 191(5):646-51. PubMed ID: 16647353 [TBL] [Abstract][Full Text] [Related]
12. Determination of TP53 mutation is more relevant than microsatellite instability status for the prediction of disease-free survival in adjuvant-treated stage III colon cancer patients. Westra JL; Schaapveld M; Hollema H; de Boer JP; Kraak MM; de Jong D; ter Elst A; Mulder NH; Buys CH; Hofstra RM; Plukker JT J Clin Oncol; 2005 Aug; 23(24):5635-43. PubMed ID: 16110022 [TBL] [Abstract][Full Text] [Related]
13. p53 is an independent pre-treatment markers for long-term survival in stage II and III colorectal cancers: an analysis of interaction between genetic markers and fluorouracil-based adjuvant therapy. Tang R; Wang JY; Fan CW; Tsao KC; Chen HH; Wu CM; Chen JS; Changchien CR; Hsieh LL Cancer Lett; 2004 Jul; 210(1):101-9. PubMed ID: 15172127 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic features in colorectal cancer patients with microsatellite instability. Raut CP; Pawlik TM; Rodriguez-Bigas MA Mutat Res; 2004 Dec; 568(2):275-82. PubMed ID: 15542114 [TBL] [Abstract][Full Text] [Related]
16. Adjuvant chemotherapy of stage III colon cancer. Benson AB Semin Oncol; 2005 Dec; 32(6 Suppl 9):S74-7. PubMed ID: 16399437 [TBL] [Abstract][Full Text] [Related]
17. Characterization of tumour-infiltrating lymphocytes and apoptosis in colitis-associated neoplasia: comparison with sporadic colorectal cancer. Michael-Robinson JM; Pandeya N; Walsh MD; Biemer-Huttmann AE; Eri RD; Buttenshaw RL; Lincoln D; Clouston AD; Jass JR; Radford-Smith GL J Pathol; 2006 Feb; 208(3):381-7. PubMed ID: 16315333 [TBL] [Abstract][Full Text] [Related]
18. Advances in chemotherapy for colorectal cancer. Bernold DM; Sinicrope FA Clin Gastroenterol Hepatol; 2006 Jul; 4(7):808-21. PubMed ID: 16797250 [TBL] [Abstract][Full Text] [Related]
19. Immunogenic hsp-70 is overexpressed in colorectal cancers with high-degree microsatellite instability. Banerjea A; Feakins RM; Nickols CD; Phillips SM; Powar MP; Bustin SA; Dorudi S Dis Colon Rectum; 2005 Dec; 48(12):2322-8. PubMed ID: 16258706 [TBL] [Abstract][Full Text] [Related]
20. Analysis of apoptosis protein expression in early-stage colorectal cancer suggests opportunities for new prognostic biomarkers. Krajewska M; Kim H; Kim C; Kang H; Welsh K; Matsuzawa S; Tsukamoto M; Thomas RG; Assa-Munt N; Piao Z; Suzuki K; Perucho M; Krajewski S; Reed JC Clin Cancer Res; 2005 Aug; 11(15):5451-61. PubMed ID: 16061861 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]